Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

Text correction

In the published article, there were two errors: The “Material and methods” section preceded the “Introduction” section, and there was an inaccuracy in the wording of a sentence in the “Reagents” sub-section of “Material and methods”.

The “Introduction” now precedes the “Material and methods”, and a correction has been made to a sentence in “Materials and methods”, sub-section “Reagents”.

This sentence previously stated:

“Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity ≥85%, and used at a final concentration of 1.5mg/mL each.”

The corrected sentence appears below:

“Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity ≥85% and stored at a final concentration of 1.5mg/mL.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.